Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer
Clinical trial NCT00912444 · TERMINATED
Trial details
- NCT number
- NCT00912444
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2012-05-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.